The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of DNA damage repair (DDR) alterations and the tumor immune microenvironment (TIME) in advanced non-small cell lung cancer (NSCLC).
 
Kamya Sankar
No Relationships to Disclose
 
Jacob Mercer
Employment - Helsinn Therapeutics; QED Therapeutics; Tempus AI
Stock and Other Ownership Interests - Bridgebio
Travel, Accommodations, Expenses - Helsinn Therapeutics; Tempus AI
 
Ellen B. Jaeger
Employment - Tempus AI, Inc
Stock and Other Ownership Interests - Tempus AI, Inc; Tempus AI, Inc
 
Jen Godden
Employment - Tempus
Travel, Accommodations, Expenses - Tempus
 
Jonathan David Berkman
No Relationships to Disclose
 
Edward Williams
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Michael A. Thompson
Employment - Aurora Health Care; Tempus AI, Inc
Stock and Other Ownership Interests - Doximity; Tempus; Tryp Therapeutics
Consulting or Advisory Role - Takeda; VIA Oncology
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Other Relationship - Doximity
 
Shetal Arvind Patel
Consulting or Advisory Role - Astellas Pharma; G1 Therapeuti; IQvia
Research Funding - Amgen (Inst); ASCO (Inst); BeiGene (Inst); Dracen (Inst); Genentech/Roche (Inst); Loxo/Lilly (Inst); Macrogenics (Inst); Seagen (Inst); Shattuck Labs (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Genentech; GlaxoSmithKline; Janssen Oncology; Lilly; Mirati Therapeutics; Novocare; Seagen
Research Funding - Blueprint Medicines; Calithera Biosciences (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst)
 
Frank Weinberg
Consulting or Advisory Role - Jazz Pharmaceuticals; Regeneron; Tempus; Tempus
Speakers' Bureau - Amgen; AstraZeneca; Regeneron; Tempus